REGENXBIO, Inc. (RGNX)
8.53
-0.03
(-0.35%)
USD |
NASDAQ |
Sep 11, 16:00
8.52
-0.01
(-0.12%)
After-Hours: 20:00
REGENXBIO Price to Book Value : 6.438 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.438 |
| September 10, 2026 | 6.461 |
| September 09, 2026 | 6.589 |
| September 08, 2026 | 6.612 |
| September 04, 2026 | 6.747 |
| September 03, 2026 | 6.944 |
| September 02, 2026 | 7.246 |
| September 01, 2026 | 7.034 |
| August 31, 2026 | 7.17 |
| August 28, 2026 | 7.291 |
| August 27, 2026 | 7.072 |
| August 26, 2026 | 7.080 |
| August 25, 2026 | 6.725 |
| August 24, 2026 | 6.079 |
| August 21, 2026 | 8.091 |
| August 20, 2026 | 8.347 |
| August 19, 2026 | 9.072 |
| August 18, 2026 | 8.355 |
| August 17, 2026 | 8.551 |
| August 14, 2026 | 8.125 |
| August 13, 2026 | 8.046 |
| August 12, 2026 | 8.234 |
| August 11, 2026 | 8.038 |
| August 10, 2026 | 7.864 |
| August 07, 2026 | 8.091 |
| Date | Value |
|---|---|
| August 06, 2026 | 8.514 |
| August 05, 2026 | 7.925 |
| August 04, 2026 | 7.774 |
| August 03, 2026 | 7.517 |
| July 31, 2026 | 7.313 |
| July 30, 2026 | 7.638 |
| July 29, 2026 | 7.261 |
| July 28, 2026 | 7.246 |
| July 27, 2026 | 7.328 |
| July 24, 2026 | 7.344 |
| July 23, 2026 | 7.736 |
| July 22, 2026 | 7.698 |
| July 21, 2026 | 7.804 |
| July 20, 2026 | 7.789 |
| July 17, 2026 | 7.464 |
| July 16, 2026 | 8.453 |
| July 15, 2026 | 9.261 |
| July 14, 2026 | 9.276 |
| July 13, 2026 | 9.623 |
| July 10, 2026 | 10.53 |
| July 09, 2026 | 11.81 |
| July 08, 2026 | 11.49 |
| July 07, 2026 | 11.34 |
| July 06, 2026 | 11.19 |
| July 02, 2026 | 10.02 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Capricor Therapeutics, Inc. | 1.975 |
| United Therapeutics Corp. | 3.315 |
| Ardelyx, Inc. | 5.986 |
| Biomea Fusion, Inc. | 10.39 |
Price to Book Value Related Metrics
| PS Ratio | 2.553 |
| PEG Ratio | -0.2435 |
| Price | 8.53 |
| Earnings Yield | -44.37% |
| Market Cap | 462.02M |
| PEGY Ratio | -0.2435 |